Anja Lorch
Papers
2
Total Citations
2,750
H-Index
2
About
Dr. Anja Lorch is a leading figure in uro-oncology, whose work has fundamentally shaped the clinical management of muscle-invasive and metastatic bladder cancer. Her primary research focus lies in developing and disseminating evidence-based guidelines that standardize and improve treatment outcomes for patients with these aggressive malignancies. As a key contributor to the European Association of Urology (EAU) guidelines, Dr. Lorch has been instrumental in synthesizing complex clinical trial data into actionable recommendations. Her landmark 2020 summary of the EAU guidelines has amassed over 2,100 citations, serving as a cornerstone reference for urologists and oncologists worldwide. The subsequent 2023 update, with over 600 citations, demonstrates her ongoing commitment to integrating the latest therapeutic advances, including immunotherapy and targeted agents, into clinical practice. Beyond guideline authorship, Dr. Lorch’s work has directly influenced the standard of care for bladder cancer, bridging the gap between cutting-edge research and real-world patient management. Her contributions have not only defined best practices but also provided a clear roadmap for future clinical trials, cementing her legacy as a pivotal architect of modern bladder cancer therapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2